Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.

Chapin-Bardales, Johanna; Gee, Julianne; Myers, Tanya

Chapin-Bardales, Johanna; Gee, Julianne; Myers, Tanya.

Chapin-Bardales J; CDC COVID-19 Response Team, Atlanta, Georgia.
Gee J; CDC COVID-19 Response Team, Atlanta, Georgia.
Myers T; CDC COVID-19 Response Team, Atlanta, Georgia.

JAMA ; 325(21): 2201-2202, 2021 06 01.

Article in English | MEDLINE | ID: covidwho-1274630

Subject(s)

COVID-19 Vaccines/adverse effects; Age Factors; Aged; COVID-19/prevention & control; Centers for Disease Control and Prevention, U.S.; Humans; Middle Aged; Population Surveillance; SARS-CoV-2/genetics; United States; Vaccines, Synthetic/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines Topics: Vaccines Limits: Aged / Humans / Middle aged Country/Region as subject: North America Language: English Journal: JAMA Year: 2021 Document Type: Article Affiliation country: Jama.2021.5374

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google